Loading insider details...
Beta
Latest Form 4 (Jun 3, 2026): Grant/Award of 18,518 ENVB shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Jun 3, 2026 | Enveric Biosciences, Inc. (ENVB) | Grant/Award | 18,518 | n/a |
| Dec 30, 2025 | Enveric Biosciences, Inc. (ENVB) | Grant/Award | 7,633 | n/a |
| Oct 11, 2024 | Enveric Biosciences, Inc. (ENVB) | Grant/Award | 47,733 | n/a |
| Sep 19, 2023 | Enveric Biosciences, Inc. (ENVB) | Purchase | 1,000 | $2.1K |
| Nov 24, 2021 | Theravance Biopharma, Inc. (TBPH) | Tax Withholding | 3,779 | $31.6K |
| Aug 24, 2021 | Theravance Biopharma, Inc. (TBPH) | Tax Withholding | 3,779 | $53.1K |
| May 24, 2021 | Theravance Biopharma, Inc. (TBPH) | Tax Withholding | 3,779 | $67.3K |
| Feb 23, 2021 | Theravance Biopharma, Inc. (TBPH) | Tax Withholding | 26,961 | $506.6K |
| Feb 10, 2021 | Theravance Biopharma, Inc. (TBPH) | Grant/Award | 65,000 | n/a |
| Nov 24, 2020 | Theravance Biopharma, Inc. (TBPH) | Tax Withholding | 4,214 | $72.5K |